the aid library

LIST OPTIONS

Filter

6742

Guidance and technical packages on community mental health services: promoting person-centred and rights-based approaches

World Health Organization WHO (2021) C_WHO

The WHO Guidance on community mental health services: Promoting person-centred and rights-based approaches document is part of the WHO Guidance and technical packages on community mental health serv... more

Download (162)

View PDF (203)

East and Horn of Africa COVID-19 Strategic Response and Recovery Plan 2021

International Organization for Migration IOM (2021) CC

Download (130)

View PDF (285)

Developing and Strengthening Community Health Worker Programs at Scale, A Reference Guide for Program Managers and Policy Makers

USAID, MCHIP (2013) CC

Recently, a renewed interest in large-scale community health worker (CHW) programs has been seen globally. This renewal provides an opportune moment to take stock of issues and challenges such programs face ... what can be done to make them as effective as possible. With this in mind, this manual is intended to be used a practical guide for policymakers and program managers wishing to develop or strengthen a CHW program, drawing lessons from other countries that have implemented CHW programs at-scale. Throughout, we discuss major policy and programmatic issues that decision-makers and planners need to consider when designing, implementing, scaling up or strengthening a national-level CHW program. We offer an overview of specific challenges CHW programs face, country lessons, tools, and other resources that may be helpful, while incorporating relevant programmatic examples as much as possible. more

Finding the Balance: Public health and social measures in Nigeria

Partnership for Evidence-Based Response to COVID-19 (PERC) (2021) CC

October 2021

Download (133)

View PDF (205)

2021 WHO health and climate change global survey report

World Health Organization (WHO) (2021) CC

The 2021 WHO health and climate change global survey report provides a valuable snapshot of the overall progress governments have made in addressing the health risks of climate change. The findings on key health ... climate change indicators aim to empower policy makers to: make informed decisions on the implementation of policies and plans; identify evidence gaps; and better understand the barriers to achieving adaptation and resilience priorities in the health sector while maximizing the health benefits of sector-wide climate mitigation efforts. more

External Link

Nature-Based Solutions and Protected Areas to Improve Urban Biodiversity and Health

MacKinnon,K.; van Ham, C.; Reilly, K.; et al. Springer International Publishing (2019) CC

Biodiversity and healthy natural ecosystems, including protected areas in and around cities, provide ecosystem benefits and services that support h... more

Download (186)

View PDF (233)

Nurses and midwives: a vital resource for health

World Health Organization WHO, Regional Office of Europe (2022) C_WHO

This European compendium was produced to provide operational examples of the new nursing and midwifery roles and new service delivery models currently being employed across the Region. The case stud... more

External Link

Schistosomiasis: Still a Cause of Significant Morbidity and Mortality

Verjeen, M. National Library of Medicine (2019) CC

Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from... more

External Link

Macroeconomics and health : investing in health for economic development / report of the Commission on Macroeconomics and Health

World Health Organization WHO (2002) C_WHO

The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood ... more

Download (289)

View PDF (385)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Asthma in South African adolescents: a time trend and risk factor analysis over two decades

Baard, C.B.; Franckling-Smith, Z.; Munro, J. et al. ERJ Open Research (2021) CC

The article "Asthma in South African adolescents: a time trend and risk factor analysis over two decades" investigates the prevalence and risk factors for asthma in Cape Town adolescents from 2002 t... more

Download (1117)

View PDF (1967)

International and National Actions in Response to a Radiation Emergency

Wisner, B.; Adams, J World Health Organization WHO (2003) C_WHO

Annex of Environmental Health in Emergencies and Disaster; page 245 - 252 Information in Tables 1–4 summarizes the actions of the World Health Organization, the International Atomic Energy Authority, other international organizations, ... local health authorities in response to a nuclear accident, in compliance with the Convention on Early Notification and the Assistance Convention. more

Download (1477)

View PDF (2194)

Rabies Pre and Post-exposure Prophylaxis in Humans

WHO (2010)

Guide; revised 15 June 2010

Download (2999)

View PDF (611)

Knowledge, attitude and practice with regards to tuberculosis and human immunodefiency virus co-infection among patients with tuberculosis in Walvis BayISTRICT, NAMIBIA.

Musana, J.I. University of Western Cape (2011) C2

Download (193)

View PDF (365)

Improving Prison Conditions by Strengthening the Monitoring of HIV, HCV, TB and Harm Reduction (Greece)

C. Kalpaki, M. Moudatsou, E. Maraki, et al. PRAKSIS; European Union (2015) C2

Mapping Report - Greece.

Download (490)

View PDF (669)

Antimicrobial Use and Resistance in Nigeria

Federal Ministries of Agriculture, Environment and Health (2017) C2

SITUATION ANALYSIS AND RECOMMENDATIONS

Download (291)

View PDF (685)

Abuses and Denial of Aid Endangering Ethnic Minorities in Northern Myanmar

Refugees International (2018) C1

In northern Myanmar, nearly 100,000 people continue to live in displacement camps in Kachin and northern Shan States. Most were first displaced by fighting between the Myanmar military and the Kachi... more

Download (419)

View PDF (817)

Chemical and Biological Agents, Nuclear Events

Smithsonian Alerts (2018) C2

Download (258)

View PDF (547)

The VISHRAM (VIdarbha Stress and Health ProgRAM) Toolkit

Rahul Shidhaye Sangath (2017) C1

Scaling Up Mental Health Care In Rural India

External Link

Tuberculosis and HIV co-infection—focus on the Asia-Pacific region

Q.M. Trinh; H.L. Nguyen; V.N. Nguyen International Journal of Infectious Diseases; Elsevier Ltd (2014) C2

International Journal of Infectious Diseases 32 (2015) 170–178 http://dx.doi.org/10.1016/j.ijid.2014.11.023 1201-9712/ß 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http:... more